ISSN:

Journal Home

BMC Cancer Q2 Unclaimed

BioMed Central Ltd. United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

BMC Cancer is a journal indexed in SJR in Genetics and Oncology with an H index of 139. It is an CC BY + CC0 Journal with a Single blind Peer Review review system, and It has a price of 2390 €. The scope of the journal is focused on cancer. It has an SJR impact factor of 1.134 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 1.134.

BMC Cancer focuses its scope in these topics and keywords: cancer, breast, patients, cell, expression, ovarian, study, human, therapy, lung, ...

Type: Journal

Type of Copyright: CC BY + CC0

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Cancer Research (Q2) Genetics (Q2) Oncology (Q2)

Price

2390 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1.134

SJR Impact factor

139

H Index

1325

Total Docs (Last Year)

3740

Total Docs (3 years)

51498

Total Refs

17667

Total Cites (3 years)

3739

Citable Docs (3 years)

4.42

Cites/Doc (2 years)

38.87

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Human Gene Therapy Q2
Heredity Q2
Genetic Epidemiology Q2
Mammalian Genome Q2
Genes and Cancer Q2

Compare this journals